DiaMedica Therapeutics
DMAC
DMAC
38 hedge funds and large institutions have $11.3M invested in DiaMedica Therapeutics in 2023 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 12 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.76% less ownership
Funds ownership: 11.2% → 10.44% (-0.76%)
77% less call options, than puts
Call options by funds: $6K | Put options by funds: $26K
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
38
Holding in Top 10
–
Calls
$6K
Puts
$26K
Top Buyers
| 1 | +$421K | |
| 2 | +$125K | |
| 3 | +$85.2K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$78.4K |
| 5 |
Jane Street
New York
|
+$67.5K |
Top Sellers
| 1 | -$592K | |
| 2 | -$548K | |
| 3 | -$69K | |
| 4 |
TWC
TD Waterhouse Canada
Toronto,
Ontario, Canada
|
-$1.89K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$1.12K |